Get the Daily Brief
Latest Biotech News
FDA Leadership Exodus Continues Amid Regulatory Shifts
The U.S. Food and Drug Administration is experiencing significant leadership turnover as Jacqueline Corrigan-Curay, acting director of the Center for Drug Evaluation and Research (CDER), announced...
Breakthrough in Cancer Chemotherapy Resistance Prediction
Researchers from the Spanish National Cancer Research Centre, in collaboration with the University of Cambridge and Tailor Bio, have developed a novel genomic test capable of predicting...
Novel Oral Drug Candidate Challenges GLP-1 Therapies for Diabetes and Obesity
A promising new oral β2 adrenergic receptor agonist exhibiting GRK-biased signaling emerges as a potential alternative to injectable GLP-1 receptor agonists in treating type 2 diabetes and...
Advances in CAR-T Cell Therapy Targeting Tumor Microenvironment
Recent innovations in chimeric antigen receptor T-cell (CAR-T) therapy are addressing critical limitations in lymphoma treatment by engineering cells capable of overcoming tumor microenvironment...
Robotic and AI Innovations in Airway Management
Emerging technologies in robotic-assisted intubation and artificial intelligence anatomical recognition are revolutionizing airway management in emergency and anesthetic care. Advanced flexible...
Novel PET Tracers Enhance Cancer Detection and Immunotherapy Guidance
Advancements in positron emission tomography (PET) imaging tracers are improving cancer diagnosis and treatment personalization. Newly developed peptide-based tracers targeting immune checkpoint...
AI Chatbots Struggle to Counter Health Misinformation
Recent research highlights significant vulnerabilities in large language models (LLMs) used as AI chatbots, which can be manipulated to disseminate inaccurate and misleading health information....
Robust Advances in Diabetes Cell Therapy from Vertex Pharmaceuticals
Vertex Pharmaceuticals’ pioneering cell therapy for type 1 diabetes, zimislecel, demonstrated promising Phase 1/2 data showing that 10 of 12 patients achieved insulin independence at least one...
Cidara’s CD-388 Floats Ahead in Flu Prevention Race
Cidara Therapeutics announced positive mid-stage Phase 2b data for its long-acting antiviral biologic CD-388, designed to prevent seasonal influenza. The drug demonstrated 76% efficacy in...
FDA Faces Leadership Exodus Amid Regulatory Shifts
The FDA is undergoing significant senior leadership turnover, intensifying industry and market uncertainty. Jacqueline Corrigan-Curay, acting director of the Center for Drug Evaluation and...
Illumina Bolsters Proteomics With SomaLogic Acquisition
Genomic sequencing leader Illumina has agreed to acquire proteomics firm SomaLogic from Standard BioTools for up to $425 million. The acquisition enhances Illumina’s multiomics portfolio by...
Advances in GLP-1 and Obesity Therapeutics Shake Market
New clinical findings at ADA 2025 highlight continued innovation and competition in obesity and diabetes treatments centered on GLP-1 receptor agonists. Amgen’s obesity drug MariTide showed...
Cancer Chemotherapy Resistance Biomarkers Show Promise
New research led by the Spanish National Cancer Research Centre and University of Cambridge, in collaboration with startup Tailor Bio, has developed genomic tests using chromosomal instability...
Breakthroughs in Alzheimer’s and Neurodegenerative Research
Recent studies have further elucidated the molecular underpinnings of Alzheimer’s disease and neurodegeneration. Weill Cornell researchers demonstrated that a rare APOE3 Christchurch gene mutation...
Innovations in CAR-T and Cell Therapy Expanding Treatment Reach
CAR-T cell therapy continues to evolve with next-generation constructs designed to overcome tumor heterogeneity and immunosuppressive microenvironments. Multi-targeting CAR-T cells and engineered...
Agricultural and Environmental Biotech Research Highlights
Several studies emphasize innovations addressing agricultural resilience and environmental sustainability. USDA-funded research investigates Hurricane Helene’s flood sediment impacts on Tennessee...
Oncology Advances Spotlight: Roche and Exelixis Lead Trials
Robust clinical trial data underscore progress in oncology. Roche’s Phase 3 Sunmo trial shows that combining bispecific antibody Lunsumio with ADC Polivy substantially outperforms standard chemo...
AI’s Expanding Role in Climate and Healthcare Data Management
Artificial intelligence continues to promise transformative impacts across sectors. Research published by the Grantham Research Institute predicts AI-enabled technologies could reduce global...
Orcas Use Kelp as Grooming Tools in Social Behavior
Recent drone footage in the Salish Sea has revealed that southern resident killer whales engage in tool use by breaking off bull kelp stalks to groom themselves and close pod-mates. This novel...
Illumina’s Strategic Acquisition of SomaLogic in Proteomics
Illumina has agreed to acquire SomaLogic and related assets from Standard BioTools for up to $425 million, reinforcing its commitment to expanding proteomics capabilities and multiomics...